Jason Langley1, Kristy S. Hwang2,3, Daniel E. Huddleston4, and Xiaoping Hu1,5
1Center for Advanced Neuroimaging, University of California Riverside, Riverside, CA, United States, 2Department of Neurosciences, University of California San Diego, San Diego, CA, United States, 3Parkinson & Other Movement Disorders Center, University of California San Diego, San Diego, CA, United States, 4Department of Neurology, Emory University, Atlanta, GA, United States, 5Department of Bioengineering, University of California Riverside, Riverside, CA, United States
Synopsis
We examine nigral
volume and tissue microstructure in prodromal and symptomatic Parkinson’s
disease. Decreases in nigral
volume were observed in the symptomatic Parkinson's disease group relative to the control group (p<10-3) and prodromal Parkinson's disease (p<10-3) group. A
reduction in nigral volume was seen in the prodromal Parkinson's disease group relative to the
control group (p=0.025). An increase in
nigral free water was also found in the symptomatic Parkinson’s disease group relative to
the control group (p=0.014).
Introduction
Parkinson’s
disease (PD) is a progressive, neurodegenerative disorder characterized by
asymmetrical onset of motor symptoms such as bradykinesia, rigidity, and
tremor. The loss of melanized catecholaminergic neurons in substantia nigra
pars compacta (SNpc) is a principal pathologic feature of PD1,2 and up
to 50% of melanized neurons in SNpc are lost at the time of onset of
Parkinsonian symptoms.2 Melanized
neurons in these SNpc can be imaged in vivo using implicit or explicit
magnetization transfer (MT) effects3-5 and magnetization transfer
contrast (MTC) colocalizes with melanized neurons.6 Implicit MT
effects are generated by an interleaved multislice turbo spin echo acquisition7
and explicit MT effects can be generated by a MT preparation pulse5
or fat saturation pulse.4
Application
of magnetization transfer effects to investigate PD-related changes in
catecholamine nuclei have revealed reductions in nigral volume7,8 or
nigral contrast4,9 in prodromal and clinically manifest PD cohorts. Other
work examining microstructural changes has found increases in the free water
compartment in prodromal and overt PD.10-12 Here, we examine nigral
volume loss and microstructural changes in a prodromal and symptomatic PD cohort.Methods
Data
was obtained from the Parkinson’s Progression Markers Initiative (PPMI)
database (www.ppmi-info.org/data). For up-to-date information on the study,
visit www.ppmi-info.org. Full inclusion and exclusion criteria for enrollment
in PPMI can be found at www.ppmi-info.org. Institutional IRB approved the study
for each site and subjects gave written informed consent. Criteria for
inclusion for subjects from the PPMI database used in this analysis were as
follows: 1) participants must be scanned with cardiac-gated diffusion tensor
imaging (DTI) and dual echo turbo-spin echo (TSE) with a fat saturation pulse,
2) participants must have DTI and TSE scans with scan parameters matching those
in the PPMI imaging protocol, and 3) PD subjects must have scan data at the 24
month time point. A total of 165 subjects (33 controls, 21 prodromal, 111 PD
patients) met this criteria. Demographic information for this cohort is
summarized in Table 1.
T1-weighted
structural images in the PPMI cohort were used for registration to common
space. Dual TSE images were acquired with the following parameters: TE1/TE2/TR=11/101/3270
ms, FOV=240×213 mm2, voxel size=0.9×0.9×3 mm3, fat
saturation pulse, 48 slices. The first echo of the TSE acquisition contains
magnetization transfer effects from the fat saturation pulse and interleaved
TSE acquisition. Cardiac-gated diffusion-MRI data in the PPMI cohort were
acquired using a monopolar diffusion encoding gradient with 64 unique gradient
directions and the following parameters: TE/TR=88/650-1100 ms, flip
angle=90.0°, FOV=229×229 mm2, voxel size=1.98×1.98×2 mm3,
b=1000 s/mm2,
cardiac-triggered, with 72 slices.
Transformations
between subject space and common space were derived using nonlinear transforms
in FSL. A boundary-based registration cost function was then used to derive a
transform between the T1-weighted image and the first TSE image and b=0 images.
DTI
data were corrected for motion and eddy-current distortions using EDDY in FSL.
Next, susceptibility distortions were reduced by nonlinearly fitting the b=0 image to second echo from the TSE
acquisition. A bi-compartment model,13 implemented in DIPY,14
was used to construct free water maps. Mean SNpc free water was measured for
each subject using previously reported probabilistic standard space mask.15
Data
from the first echo in the TSE acquisition has magnetization transfer effects
and was used to segment SNpc. SNpc was segmented using a thresholding method. A
reference region was drawn in the cerebral peduncle in MNI common space and
then transformed to individual NM-MRI images and used to threshold. Voxels with
intensity >μref+3σref were considered
to be part SNpc. Thresholding was restricted to the anatomic location of SNpc
using previously reported probabilistic standard space mask.14
Results
A comparison of SNpc
contrast in the first echo from the TSE acquisition and free water images for prodromal PD,
symptomatic PD, and control subjects are shown in Figures 1 and 2, respectively. The effect of group
(symptomatic PD, prodromal PD, control) was tested with separate analysis of covariance
(ANCOVA) in each MRI measure (SNpc volume free water), controlling for age. A
significant main effect in group (p<10-4;F=25.12) was seen for SNpc volume. Pairwise-comparisons showed
decreases in SNpc volume in the symptomatic PD group relative to the control
group (p<10-3) and prodromal
(p<10-3) groups. Relative
to the control group, reduced SNpc volume was seen in the prodromal PD group (p=0.025). Similarly, a significant main
effect in group was seen in SNpc free water (p=0.046;F=3155) with
means showing increases in SNpc free water in the symptomatic PD group
relative to control group (p=0.014).
No difference was seen in SNpc free water between prodromal PD and control (p=0.323) or symptomatic PD groups (p=0.357).Discussion
We found reductions
in nigral volume in the prodromal PD and symptomatic PD groups relative to
controls and an increase in nigral free water in the symptomatic PD group
relative to controls. A reduction in contrast was observed in the posterior
regions of SNpc (Figure 1). This is in agreement with earlier studies that
found volume a reduction of neuromelanin-sensitive contrast in the posterior
portion of SNpc.8 Increases in SNpc free water are also observed in
the symptomatic PD group relative to the control group but not the prodromal PD
group and agrees with earlier studies.10-12Acknowledgements
Data used in this abstract was collected by PPMI. PPMI
– a public-private partnership – is funded by the Michael J. Fox Foundation for
Parkinson’s Research and funding partners, including [list the full names of
all of the PPMI funding partners found at www.ppmi-info.org/fundingpartners].References
[1] Braak, et
al. Staging of brain pathology related to sporadic Parkinson's disease.
Neurobiol Aging, 24:197-211
[2] Fearnley & Lees. Ageing and
Parkinson’s disease: substantia nigra regional selectivity. Brain 114:2283-2301
[3] Sasaki, et al.
Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra
in Parkinson's disease. Neuroreport. 17:1215-8
[4] Schwarz, et al. T1-Weighted MRI shows stage-dependent substantia
nigra signal loss in Parkinson's disease. Movement Disorders. 26:1633–38
[5] Chen, et al. Simultaneous imaging of
locus coeruleus and substantia nigra with a quantitative neuromelanin MRI
approach. Magn Reson Imaging. 32:1301-6
[6] Keren, et al. Histologic validation of locus coeruleus MRI contrast in
post-mortem tissue. Neuroimage, 113:235-245
[7] Dixon, et al. Incidental magnetization transfer contrast in standard
multislice imaging. Magn Reson Imaging, 8:417-22
[7] Ogisu, et al. 3D
neuromelanin-sensitive magnetic resonance imaging with semi-automated volume
measurement of the substantia nigra pars compacta for diagnosis of Parkinson’s
disease, Neuroradiology 55:719–724
[8] Schwarz, et al. In vivo assessment of brainstem
depigmentation in Parkinson disease: potential as a severity marker for multicenter
studies, Radiology :160662
[9] Reimao, et al. Substantia nigra neuromelanin
magnetic resonance imaging in de novo Parkinson’s disease patients, Eur. J.
Neurol. 22: 540–546
[10] Guttuso, et al. Substantia Nigra Free Water
Increases Longitudinally in Parkinson Disease. AJNR Am J Neuroradiol. Mar
2018;39(3):479-484
[11] Burciu, et al. Progression marker of Parkinson's
disease: a 4-year multi-site imaging study. Brain. 140:2183-2192
[12] Zhou, et al. Increased free water in the
substantia nigra in idiopathic REM sleep behaviour disorder. Brain,
144:1488-1497.
[13] Pasternak, et al. Free water elimination and
mapping from diffusion MRI. Magn Reson Med. 62:717-30
[14] Garyfallidis,
et al. Dipy, a library for the
analysis of diffusion MRI data. Front Neuroinform. 2014;8:8
[15] Langley, et al. Characterization of age-related
microstructural changes in locus coeruleus and substantia nigra pars compacta.
Neurobiol Aging, 87:89-97